15 results · 19ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

DIAMOND ALOE VERA, STERILE

FDA 510(k)
FDA Unclassified ·Unknown

ODYSSEY®

FDA UDI
Microport Orthopedics Inc.·M684K00126661·

Alteon

FDA UDI
Exactech, Inc.·10885862630292·Curved Modular Rasp

Merit Medical®

FDA UDI
Merit Medical Systems, Inc.·00884450182239·

TC-PLUS SOLUTION KNEE

FDA 510(k)
FDA Class 2 ·Orthopedic

MODIFICATION TO INTUITIVE SURGICAL STEREO VIEW ENDOSCOPIC SYSTEM

FDA 510(k)
FDA Class 2 ·Gastroenterology, Urology

LUMA ARCH

FDA Adverse Event
Injury ·LUMALITE, INC.·Product code EEG·July 6, 2004

Span-America

FDA UDI
SPAN-AMERICA MEDICAL SYSTEMS, INC.·H93300266600000·ZIMMER CAST ELEVATOR 6/CS

VERSAFITCUP DM DOUBLE MOBILITY HC LINER 50/28

FDA Adverse Event
Injury ·MEDACTA INTERNATIONAL SA·Product code MEH·May 17, 2021

ATLAS MONITOR

FDA Adverse Event
Malfunction ·WELCH ALLYN PROTOCOL, INC.·Product code DQA·February 13, 2013

LIFEVEST WCD 3100 SYSTEM

FDA Adverse Event
Malfunction ·ZOLL LIFECOR CORPORATION·Product code MVK·February 9, 2011

ACCU-CHEK AVIVA

FDA Adverse Event
Malfunction ·ROCHE DIAGNOSTICS·Product code NBW·February 8, 2008

Boston Scientific/Cameron Health SQ-RX Model 1010 subcutaneous pulse generators. The S-ICD System is intended to provide therapy for the treatment of life-threatening ventricular tachyarrhythmias.

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·March 27, 2013

1202 Flex Focus Ultrasound System, cart models UA1214 and UA1814, used with: Flex Focus 200, Flex Focus 300, Flex Focus 400, Flex Focus 500, Flex Focus 700, Flex Focus 800; System, Imaging, Pulsed Doppler, Ultrasonic

FDA Enforcement
Class II ·Ongoing·B-K Medical A/S·November 12, 2025

CADD-Solis Ambulatory Infusion Pumps, Model 2100. Intended for the following uses: Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.

FDA Enforcement
Class I ·Ongoing·Smiths Medical ASD Inc.·August 14, 2024